When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm teams up with CRO in study of selinexor in COVID-19
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (KPTI-5.3%) is collaborating with contract research organization (CRO) PROMETRIKA on an international, randomized, 230-subject study evaluating low-dose Xpovio (selinexor) in severely ill hospitalized COVID-19 patients.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news,